COMPOUNDS AND THEIR USE FOR THE TREATMENT OF ALPHA1-ANTITRYPSIN DEFICIENCY

The invention relates to oxopyrimidinyl-methyl-benzamide derivatives, for example in a pharmaceutically acceptable salt form or crystal form, pharmaceutical compositions comprising the derivatives, and their medical use, in particular for use in the treatment of α1-antitrypsin deficiency (A1AD or AA...

Full description

Saved in:
Bibliographic Details
Main Authors JAMES ANDREW HUNTINGTON, DAVID JOHN FOX, NIGEL RAMSDEN
Format Patent
LanguageEnglish
Published 26.10.2022
Online AccessGet full text

Cover

More Information
Summary:The invention relates to oxopyrimidinyl-methyl-benzamide derivatives, for example in a pharmaceutically acceptable salt form or crystal form, pharmaceutical compositions comprising the derivatives, and their medical use, in particular for use in the treatment of α1-antitrypsin deficiency (A1AD or AATD).
Bibliography:Application Number: ZA20210003977